Molecular Diagnostic Yield of NGS and MLPA/FISH in Neurofibromatosis Type 1: A Regional Romanian Cohort Study

Background/Objectives: Neurofibromatosis type 1 (NF1) has variable clinical expression and marked allelic heterogeneity. This study assessed the diagnostic yield of molecular testing in a regional Romanian cohort with an initial clinical diagnosis of NF1 and described the clinical features of patients with NF1 molecular findings. Methods: This retrospective study included 77 patients evaluated between 1990 and 2025. We reviewed the use and results of next-generation sequencing (NGS), multiplex ligation-dependent probe amplification (MLPA), and fluorescence in situ hybridization (FISH). Results: Of the 77 patients, 42 (54.5%) underwent molecular testing. NGS was performed in 36 patients, MLPA in 15, and FISH in 7. NGS identified pathogenic or likely pathogenic NF1 sequence variants in 30 of 36 sequenced patients (83.3%), representing 30 of 42 tested patients (71.4%). In one additional patient with a negative NGS result, MLPA detected a suspected intragenic NF1 deletion that was not independently confirmed. Including this finding, the observed yield was 31/36 (86.1%) among sequenced patients and 31/42 (73.8%) among all tested patients. FISH detected no 17q11.2 microdeletions. One patient had an NF1 variant of uncertain significance. Each of the three recurrent NF1 variants was observed within a single family. A homozygous pathogenic MSH6 variant led to the reclassification of one patient as having constitutional mismatch repair deficiency (CMMRD). Conclusions: NGS identified a pathogenic or likely pathogenic NF1 variant in 30 of the 36 sequenced patients. Because access to testing and the methods used varied across the cohort, this proportion applies to the sequenced subgroup. In one child initially diagnosed with NF1, molecular testing established a diagnosis of CMMRD.

Authors

Institutions

Publication Details

Journal
Diagnostics
Published
2026-11-18
DOI
https://doi.org/10.3390/diagnostics16223848
Primary Topic
Neurofibromatosis and Schwannoma Cases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Molecular Diagnostic Yield of NGS and MLPA/FISH in Neurofibromatosis Type 1: A Regional Romanian Cohort Study

Mihai Cucu, Emilia Maria Severin, Codruța Diana Petcheși, Claudia Violeta Bănescu et al.
4 links
Diagnostics
Neurofibromatosis and Schwannoma Cases
article

Molecular Diagnostic Yield of NGS and MLPA/FISH in Neurofibromatosis Type 1: A Regional Romanian Cohort Study

Mihai Cucu, Emilia Maria Severin, Codruța Diana Petcheși, Claudia Violeta Bănescu, Aurora Alexandra Jurca, Nicoleta Ioana Andreescu, Timea Claudia Ghitea, Alexandru Daniel Jurcă, Kinga Kozma, Cosmin Mihai Vesa, Adela Chiriţă-Emandi, Ramona Hodișan, Claudia Maria Jurca, Cristina Buzlea-Zaha, Oana Iuhas
article en

Abstract

Background/Objectives: Neurofibromatosis type 1 (NF1) has variable clinical expression and marked allelic heterogeneity. This study assessed the diagnostic yield of molecular testing in a regional Romanian cohort with an initial clinical diagnosis of NF1 and described the clinical features of patients with NF1 molecular findings. Methods: This retrospective study included 77 patients evaluated between 1990 and 2025. We reviewed the use and results of next-generation sequencing (NGS), multiplex ligation-dependent probe amplification (MLPA), and fluorescence in situ hybridization (FISH). Results: Of the 77 patients, 42 (54.5%) underwent molecular testing. NGS was performed in 36 patients, MLPA in 15, and FISH in 7. NGS identified pathogenic or likely pathogenic NF1 sequence variants in 30 of 36 sequenced patients (83.3%), representing 30 of 42 tested patients (71.4%). In one additional patient with a negative NGS result, MLPA detected a suspected intragenic NF1 deletion that was not independently confirmed. Including this finding, the observed yield was 31/36 (86.1%) among sequenced patients and 31/42 (73.8%) among all tested patients. FISH detected no 17q11.2 microdeletions. One patient had an NF1 variant of uncertain significance. Each of the three recurrent NF1 variants was observed within a single family. A homozygous pathogenic MSH6 variant led to the reclassification of one patient as having constitutional mismatch repair deficiency (CMMRD). Conclusions: NGS identified a pathogenic or likely pathogenic NF1 variant in 30 of the 36 sequenced patients. Because access to testing and the methods used varied across the cohort, this proportion applies to the sequenced subgroup. In one child initially diagnosed with NF1, molecular testing established a diagnosis of CMMRD.

DiagnosticsVol. 16(22)
Carol Davila University of Medicine and Pharmacy (RO), University of Oradea (RO), University of Medicine and Pharmacy of Craiova (RO), Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș (RO), Victor Babeș University of Medicine and Pharmacy Timișoara (RO), Agora University (RO)
Good health and well-being
Neurofibromatosis and Schwannoma Cases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon